RVPH
Reviva Pharmaceuticals Holdings Inc.
NASDAQ: RVPH · HEALTHCARE · BIOTECHNOLOGY
$0.87
+0.43% today
Updated 2026-04-30
Market cap
$11.68M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-5.48
Dividend yield
—
52W range
$1 – $23
Volume
1.6M
Reviva Pharmaceuticals Holdings Inc. (RVPH) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-420.00%
ROA
-80.30%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2018 | — | $-1.68M | — | — | — |
| 2019 | $0.00 | $-846832.00 | — | — | — |
| 2020 | $0.00 | $-3.78M | — | — | — |
| 2021 | $0.00 | $-8.52M | — | — | — |
| 2022 | $0.00 | $-24.34M | — | — | — |
| 2023 | $0.00 | $-39.26M | — | — | — |
| 2024 | $0.00 | $-29.92M | — | — | — |
| 2025 | $0.00 | $-19.86T | — | — | — |